Dana P Albon

17PUBLICATIONS
20CO-AUTHORS
Learning, motivation and emotionSocial determinants of healthMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 16, 2026
Renal function decline in adults with cystic fibrosis experiencing pulmonary exacerbations.

Dana Albon

|Dec 03, 2025
Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI.

Zhuoyi Galvin Li, Deirdre Jennings, Lindsay Somerville

|Nov 17, 2025
Cutaneous Adverse Effects of Elexacaftor-Tezacaftor-Ivacaftor: A Single Center Cohort Study on Acne Severity in Adults With Cystic Fibrosis.

Aaron D Smith, Catherine E Lyons, Lindsay Somerville

|Jul 22, 2025
Improving Modulator Management and Side Effect Screening: A CF Learning Network Innovation Lab.

Kevin P Lonabaugh, Anna Saulitis, Elizabeth Boettinger

|Nov 15, 2024
Modulator-refractory cystic fibrosis: Defining the scope and challenges of an emerging at-risk population.

Lindsay Somerville, Larry Borish, Imre Noth

Pageof 3